NASDAQ
IRIX
Last Price
US $1.07
KEY FIGURES
MKT CAP
$18.6M
EPS
TTM
$-0.19
PEG
TTM
-
P/E
TTM
N/M
P/S
TTM
0.35x
YIELD
0.00%
GROWTH
Revenue Y/Y
Profit margin
Current Ratio
Capital Returns
-64.23%
Return on equity
ROIC: -16.95%
Valuation History
-5.8X
Price to Earnings
EV/EBITDA: -11.5X
Cash flow
Profit margin
6.38%
(FY vs FY)
EBITDA Y/Y
13.57%
(FY vs FY)
Cash flow Y/Y
-
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $1.07
—
Default assumptions
EBITDA Multiple
Fair Value
Market $1.07
—
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
IRIDEX Corporation cash flow to debt ratio of -46.67% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
IRIDEX Corporation has insufficient data to evaluate this check.
Financial risk - Healthy debt to equity ratio.
IRIDEX Corporation's debt to equity ratio is 0.90, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
IRIDEX Corporation has insufficient data to evaluate this check.
Financial risk - Net debt/EBITDA.
IRIDEX Corporation has negative EBITDA, making leverage ratio unreliable
Financial risk - ICR.
Interest expense is not separately reported in IRIDEX Corporation's latest filing, so interest coverage cannot be calculated.
Financial stability - Profit margin growth.
IRIDEX Corporation's profit margin has increased (-65.98%) in the last year from -18.31% to -6.23%, signaling increasing performance
Financial stability - Short term assets vs short term liabilities.
IRIDEX Corporation's short-term assets of $25.25M exceed its short-term liabilities of $13.21M
Decreasing performance - ROA.
IRIDEX Corporation's return on assets of 0.00% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
IRIDEX Corporation's return on equity of -64.23%, is lower than 15.00%, indicating bad performance
Decreasing performance - Earnings quality.
IRIDEX Corporation's operating cash flow is lower than its net income, indicating that earnings may not be fully backed by cash generation
Decreasing performance - Earnings stability.
IRIDEX Corporation had positive net income in only 0.00 out of 5 years, indicating unstable earnings
Decreasing performance - Free cash flow.
IRIDEX Corporation has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
IRIDEX Corporation has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
IRIDEX Corporation's yearly earnings has increased -50.20% since last year from $-8.91M to $-4.44M, signaling increasing performance
Decreasing performance - Healthy revenue growth.
IRIDEX Corporation has insufficient data to evaluate this check.
Decreasing performance - ROIC.
ROIC -16.95% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Decreasing performance - 3-year revenue CAGR.
IRIDEX Corporation's 3-year revenue CAGR of -2.58% is negative, indicating declining revenue over the past 3 years
Increasing performance - Revenue consistency.
IRIDEX Corporation had revenue growth in 3.00 out of 5 years, indicating consistent revenue performance
Decreasing performance - ROE consistency.
IRIDEX Corporation had positive ROE in only 0.00 out of 5 years, indicating inconsistent returns on equity
Overvalued - DCF valuation.
IRIDEX Corporation has insufficient data to evaluate this check.
Overvalued - Earnings yield.
IRIDEX Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Overvalued - EBITDA valuation.
IRIDEX Corporation is overvalued relative to its fair value price of 0.00 based on EBITDA multiple model
Overvalued - EV/EBITDA.
IRIDEX Corporation has negative or missing EBITDA, making EV/EBITDA ratio unreliable
Overvalued - PEG ratio value.
IRIDEX Corporation has negative trailing-twelve-month earnings; this ratio is not meaningful and the check fails
Undervalued - P/B ratio.
IRIDEX Corporation has a price-to-book ratio of 3.91x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
IRIDEX Corporation has a price-to-sales ratio of 0.35x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue